Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
The most frequent liver tumor in children is hepatoblastoma (HB), which derives from embryonic parenchymal liver cells or hepatoblasts. Hepatocellular carcinoma (HCC), which rarely affects young people, causes one fourth of deaths due to cancer in adults. In contrast, HB usually has better prognosis...
Main Authors: | Jose J. G. Marin, Candela Cives-Losada, Maitane Asensio, Elisa Lozano, Oscar Briz, Rocio I. R. Macias |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/3/407 |
Similar Items
-
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
by: Jose J. G. Marin, et al.
Published: (2020-07-01) -
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
by: Jose J.G. Marin, et al.
Published: (2020-02-01) -
A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
by: James A. Saltsman, et al.
Published: (2020-09-01) -
Editorial: Sirtuinome Rewiring to Hijack Cancer Cell Behavior and Hamper Resistance to Anticancer Intervention
by: Stefano Falone, et al.
Published: (2020-07-01) -
Mechanisms Involved in Chemoresistance in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01)